Winner Medical Co Ltd

Winner Medical released its 2026 interim report, with net profit attributable to the parent company of 513 million yuan. The company's total operating revenue was 5.486 billion yuan, and net cash inflow from operating activities was 313 million yuan, down 7.79% from the same period last year. The latest asset-liability ratio was 34.16%, gross margin was 49.00%, ROE was 4.40%, and diluted earnings per share was 0.88 yuan.

Winner Medical announced plans to distribute a cash dividend of 5 yuan, tax included, for every 10 shares to all shareholders, with an estimated total payout of 287 million yuan. In the first half of 2026, the company achieved revenue of 5.486 billion yuan and net profit attributable to the parent of 513 million yuan.